Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Claus Lindbjerg Andersen
With
University of Aarhus
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Colon or rectal cancer, tumor stage III (pT1-4N1-2,cM0) or stage II high-risk (pT4N0,cM0 and pT3N0, cM0 with risk factors)
Have received curative intend resection and be candidates for adjuvant chemotherapy
You may not be if
Not treated with adjuvant chemotherapy
Synchronous colorectal and non-colorectal cancer diagnosed per-operative (except skin cancer other than melanoma)
Other cancers (excluding colorectal cancer or skin cancer other than melanoma) within 3 years from screening
Patients who are unlikely to comply with the protocol (e.g. uncooperative attitude), inability to return for subsequent visits) and/or otherwise considered by the Investigator to be unlikely to complete the study.
Clareo Health | ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial
